AFM-16

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAFM-16
Drug Alias Nameanti-CD5 IgG antibody (Affimed)AFM-16
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell surface glycoprotein CD5 inhibitors
TargetsT-cell surface glycoprotein CD5
Therapy Area/IndicationsAutoimmune DiseasesLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffimed Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffimed Nv
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLeukemia

Other Information

ATC CodeN/A
Related LinksN/A